Shares of Ensign Group (ENSG) jumped 7.43% in after-hours trading on Thursday following the company's strong second-quarter earnings report and increased full-year guidance. The healthcare services provider posted better-than-expected results and raised its outlook, citing continued operational momentum across its portfolio.
For Q2 2025, Ensign reported adjusted earnings per share of $1.59, surpassing the analyst consensus estimate of $1.55. Revenue came in at $1.23 billion, also beating expectations of $1.22 billion. The company saw notable improvements in key metrics, with same-facility skilled mix increasing to 32.4% from 30.9% in the prior year quarter, and occupancy rising to 82.1% from 80.5%.
Based on the strong first half performance, Ensign raised its 2025 earnings guidance to between $6.34 and $6.46 per diluted share, up from the previous range of $6.22 to $6.38. The company also increased its annual revenue forecast to $4.99 billion to $5.02 billion, up from $4.89 billion to $4.94 billion previously. Management expressed confidence in capturing further growth opportunities, citing the significant organic potential in its existing portfolio and the successful integration of recently acquired operations.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.